alisa_li (@alisalikhitsup) 's Twitter Profile
alisa_li

@alisalikhitsup

Gastroenterology/Hepatology | Liver disease and transplant hepatologist | Clinical Assist Prof @UofM

ID: 1006163810607095810

calendar_today11-06-2018 13:18:40

486 Tweet

647 Followers

466 Following

Elliot Tapper (@ebtapper) 's Twitter Profile Photo

There is an RCT of ROTEM prior to procedures in #cirrhosis about to finish in Australia rdcu.be/djox6 Very little information on procedures included and sample size available: fill me in if you know But here is their protocol for how to respond to the ROTEM

There is an RCT of ROTEM prior to procedures in #cirrhosis about to finish in Australia 

rdcu.be/djox6

Very little information on procedures included and sample size available: fill me in if you know

But here is their protocol for how to respond to the ROTEM
AASLD (@aasldtweets) 's Twitter Profile Photo

October is #NationalLiverAwarenessMonth. Are you aware that your liver is the filter for your blood? Keep your liver healthy all year by drinking plenty of water, exercising, maintaining a healthy diet, and washing your hands. #get2knowyourliver #LiverTwitter

October is #NationalLiverAwarenessMonth. Are you aware that your liver is the filter for your blood? Keep your liver healthy all year by drinking plenty of water, exercising, maintaining a healthy diet, and washing your hands. #get2knowyourliver #LiverTwitter
LiverTox (@livertox) 's Twitter Profile Photo

Hello #livertwitter come check out @LiverTox this week at #TLM23. We have 10 oral and poster presentations on the latest #DILI research to share with you! AASLD Lily Dara Robert Fontana sidbarritt4 Raj VuppaLanchi alisa_li

Hello #livertwitter come check out @LiverTox this week at #TLM23. We have 10 oral and poster presentations on the latest #DILI research to share with you!
<a href="/AASLDtweets/">AASLD</a> <a href="/lilydaramd/">Lily Dara</a> <a href="/RobertFontanaMD/">Robert Fontana</a> <a href="/sidbarritt4/">sidbarritt4</a> <a href="/rajVuppaLanchi/">Raj VuppaLanchi</a> <a href="/AlisaLikhitsup/">alisa_li</a>
Atoosa Rabiee (@atoosarabiee) 's Twitter Profile Photo

My #livertwitter in review Highlights of new guidance statements & interesting publications in 2023 🧵1/11 From AASLD new guidance statements Portal HTN pubmed.ncbi.nlm.nih.gov/37870298/ pubmed.ncbi.nlm.nih.gov/37390489/ ACLF pubmed.ncbi.nlm.nih.gov/37939273/ Juan G Abraldes Guadalupe GarciaTsao Sumeet Asrani

My #livertwitter in review 
Highlights of new guidance statements &amp; interesting publications in 2023
🧵1/11
From <a href="/AASLDtweets/">AASLD</a> new guidance statements
Portal HTN 
pubmed.ncbi.nlm.nih.gov/37870298/
pubmed.ncbi.nlm.nih.gov/37390489/
ACLF
pubmed.ncbi.nlm.nih.gov/37939273/
<a href="/JuanAbraldes/">Juan G Abraldes</a> <a href="/ggarciatsao/">Guadalupe GarciaTsao</a> <a href="/AsraniSumeet/">Sumeet Asrani</a>
Ramon Bataller (@rabataller) 's Twitter Profile Photo

Promising results with Resmetirom (thyroid hormone receptor β agonist) in MASLD: 🔸Reduces atherogenic lipids 🔸Reduces liver fat content The effects/safety of long-term treatment should be evaluated. shorturl.at/jlpxX Nature Medicine #livertwitter #MedTwitter

Promising results with Resmetirom (thyroid hormone receptor β agonist) in MASLD:

🔸Reduces atherogenic lipids
🔸Reduces liver fat content 

The effects/safety of long-term treatment should be evaluated.

shorturl.at/jlpxX <a href="/NatureMedicine/">Nature Medicine</a> #livertwitter #MedTwitter
BJS Open (@bjsopen) 's Twitter Profile Photo

Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis ➡️doi.org/10.1093/bjsope… ☝️The 2022 Barcelona Clinic Liver Cancer (BCLC) algorithm does not recommend liver

Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis
➡️doi.org/10.1093/bjsope…

☝️The 2022 Barcelona Clinic Liver Cancer (BCLC) algorithm does not recommend liver
alisa_li (@alisalikhitsup) 's Twitter Profile Photo

“HCC-LIVE” is above and beyond. Great speakers, excellent talks. AND I enjoyed the most is multidisciplinary debates among these experts. #HCCLIVE2024 #top3cancerin46countries #practicechangingisreal #gettingoutofcomfortzone #truemultidisciplinary #betteroutcomesforHCC

“HCC-LIVE” is above and beyond. Great speakers, excellent talks. AND I enjoyed the most is multidisciplinary debates among these experts. 
#HCCLIVE2024 #top3cancerin46countries 
#practicechangingisreal
#gettingoutofcomfortzone
#truemultidisciplinary 
#betteroutcomesforHCC
Miguel Regueiro (@mregueiromd) 's Twitter Profile Photo

Recognizing the Impact of Impostor Phenomenon and Microaggressions in Gastroenterology consultqd.clevelandclinic.org/recognizing-th…

Anjana Pillai (@anjanapillaimd) 's Twitter Profile Photo

Very insightful and emotional morning with our patient and caregiver story. The concept of “hope changes” with every stage of disease is so true -important to have the conversations early when curative options are no longer available Blue Faery HCC-LIVE Conference Arpan Patel, MD PhD (he/him/his)

Very insightful and emotional morning with our patient and caregiver story. The concept of “hope changes” with every stage of disease is so true -important to have the conversations early when curative options are no longer available <a href="/BlueFaeryLiver/">Blue Faery</a> <a href="/HCCLIVEConf/">HCC-LIVE Conference</a> <a href="/ArpanPatelMD/">Arpan Patel, MD PhD (he/him/his)</a>
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

Tu Youyou called her discovery “A Gift from Traditional Chinese Medicine to the World.” When hunting for a medicine to treat malaria, Tu turned to Chinese medical texts. Her search ended in the extraction of artemisinin – an anti-malarial that has saved millions of lives.

Tu Youyou called her discovery “A Gift from Traditional Chinese Medicine to the World.”

When hunting for a medicine to treat malaria, Tu turned to Chinese medical texts. Her search ended in the extraction of artemisinin – an anti-malarial that has saved millions of lives.
Lily Dara (@lilydaramd) 's Twitter Profile Photo

#DILI from newer IBD meds key take home Einar S. Björnsson AASLD Uma Mahadevan GIDrHwang USC Division of GI & Liver Damie Odufalu ✅Liver injury from infliximab is usually mild without jaundice. ✅There are 10 cases in the literature leading to LT. ✅Infliximab induces a

#DILI from newer IBD meds key take home <a href="/bjornsson_s/">Einar S. Björnsson</a> <a href="/AASLDtweets/">AASLD</a> <a href="/UmaMahadevanIBD/">Uma Mahadevan</a> <a href="/GIDrHwang/">GIDrHwang</a> <a href="/USC_KeckGILiver/">USC Division of GI & Liver</a> <a href="/DamieOdufaluMD/">Damie Odufalu</a> 
✅Liver injury from infliximab is usually mild without jaundice.
✅There are 10 cases in the literature leading to LT.
✅Infliximab induces a
Journal of Hepatology (@jhepatology) 's Twitter Profile Photo

Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8+ T cells Full text here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8+ T cells

Full text here👉journal-of-hepatology.eu/article/S0168-…

#LiverTwitter
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

🔥Hot off the press🔥 Durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer 🔎updated overall survival from TOPAZ-1 phase 3 The Lancet Gastroenterology & Hepatology doi.org/10.1016/S2468-… 👉24-mo OS rate: 23·6% vs 11·5% ESMO - Eur. Oncology EASLnews ILCA Cholangiocarcinoma Foundation #livertwitter

🔥Hot off the press🔥
Durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer
🔎updated overall survival from TOPAZ-1 phase 3 
<a href="/LancetGastroHep/">The Lancet Gastroenterology & Hepatology</a> 
doi.org/10.1016/S2468-…
👉24-mo OS rate: 23·6% vs 11·5%
<a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/EASLnews/">EASLnews</a> <a href="/ILCAnews/">ILCA</a> <a href="/curecc/">Cholangiocarcinoma Foundation</a> #livertwitter
Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

HDS Botanicals in the US: > 15 million Americans take potentially hepatotoxic HDS botanicals every Day ! Most self-initiated to “Boost Immunity or Energy” doi:10.1001/jamanetworkopen.2024.25822 Michigan Hepatology LiverTox Michigan Medicine

HDS Botanicals in the US: &gt; 15 million Americans take potentially hepatotoxic HDS botanicals every Day ! Most self-initiated to “Boost Immunity or Energy” doi:10.1001/jamanetworkopen.2024.25822 <a href="/MichiganLiver/">Michigan Hepatology</a> <a href="/livertox/">LiverTox</a> <a href="/umichmedicine/">Michigan Medicine</a>